Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORALEV2: Mechanical Bowel Preparation in Colonic Surgery
NCT04161599Phase 4Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Mar 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 4, randomised, open-label trial of sodium picosulfate + magnesium oxide + citric acid in surgical site infection (SSI), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Rate of Wound infection at 30 days. Status: unknown.
02
Drugs
sodium picosulfate + magnesium oxide + citric acid
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04161599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161599.